ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,911 | 100,300 | 15,254 | 24,261 | 25,073 |
| Receivables | 131,625 | 128,526 | 106,714 | 92,648 | 91,876 |
| Inventories | 83,155 | 81,693 | 61,684 | 67,634 | 59,927 |
| TOTAL | $301,399 | $321,775 | $191,384 | $191,799 | $182,798 |
| Non-Current Assets | |||||
| PPE Net | 52,713 | 52,671 | 39,526 | 40,334 | 40,767 |
| Intangibles | 309,761 | 322,010 | 173,721 | 183,779 | 182,439 |
| Other Non-Current Assets | 80,973 | 75,142 | 65,823 | 64,247 | 57,839 |
| TOTAL | $443,447 | $449,823 | $279,070 | $288,360 | $281,045 |
| Total Assets | $744,846 | $771,598 | $470,454 | $480,159 | $463,843 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 850 | 850 | 15,927 | 15,182 | 14,438 |
| Accounts payable and accrued liabilities | 22,059 | 22,967 | 11,513 | 12,977 | 13,769 |
| Accrued Expenses | 48,374 | 63,720 | 57,370 | 61,233 | 50,840 |
| TOTAL | $79,532 | $87,537 | $84,872 | $89,454 | $82,768 |
| Non-Current Liabilities | |||||
| Long Term Debt | 286,307 | 286,520 | 186,063 | 189,525 | 168,985 |
| Deferred Revenues | 116 | N/A | 62 | 62 | 62 |
| Other Non-Current Liabilities | 32,913 | 38,801 | 8,116 | 9,263 | 8,378 |
| TOTAL | $319,220 | $325,321 | $194,179 | $198,788 | $177,363 |
| Total Liabilities | $398,752 | $412,858 | $279,051 | $288,242 | $260,131 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,247 | 17,272 | 12,752 | 12,762 | 12,740 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -68,300 | -47,765 | -23,439 | -18,992 | -4,886 |
| Other shareholders' equity | 27,309 | 21,660 | -4,370 | -5,495 | -4,626 |
| TOTAL | $346,094 | $358,740 | $191,403 | $191,917 | $203,712 |
| Total Liabilities And Equity | $744,846 | $771,598 | $470,454 | $480,159 | $463,843 |